McAdam, LLC Q2 2022 Filing

Filed July 15, 2022

Portfolio Value

$945.8B

Holdings

220

Report Date

Q2 2022

Filing Type

13F-HR

All Holdings (220 positions)

#StockSharesValue% PortfolioType
201
BSXBOSTON SCIENTIFIC CORP
6,100$227.0M0.02%
202
ACNACCENTURE PLC IRELAND
815$226.0M0.02%
203
SBUXSTARBUCKS CORP
2,934$224.0M0.02%
204
PFFISHARES TR
6,685$220.0M0.02%
205
0VVBPARAMOUNT GLOBAL
8,607$212.0M0.02%
206
XLKSELECT SECTOR SPDR TR
1,666$212.0M0.02%
207
GLDMWORLD GOLD TR
5,700$205.0M0.02%
208
PPLPPL CORP
7,471$203.0M0.02%
209
QYLDGLOBAL X FDS
10,055$176.0M0.02%
210
TRYBARINGS BDC INC
10,203$95.0M0.01%
211
LPTXEURLEAP THERAPEUTICS INC
51,476$59.0M0.01%
212
PYREURPYROGENESIS CDA INC
24,197$47.0M0.00%
213
GAMIDA CELL LTD
25,629$45.0M0.00%
214
VSTMVERASTEM INC
31,572$37.0M0.00%
215
HEPION PHARMACEUTICALS INC
62,169$36.0M0.00%
216
SENS1GBPSENSEONICS HLDGS INC
25,001$26.0M0.00%
217
DESKTOP METAL INC
11,838$26.0M0.00%
218
T2 BIOSYSTEMS INC
113,201$18.0M0.00%
219
SNDLEURSUNDIAL GROWERS INC
44,027$14.0M0.00%
220
CRBPEURCORBUS PHARMACEUTICALS HLDGS
10,006$3.0M0.00%
PreviousPage 3 of 3